Ascelia Pharma’s interim report for the period January – March 2019 (Q3 2018/2019) will be published on Wednesday 15 May 2019 at 08:00 CET. A presentation for analysts, media and investors will be held the same day at 10:00 CET.
The event will be hosted by the company’s CEO Magnus Corfitzen, CFO Kristian Borbos and CMO Carl Bjartmar. The presentation will be held in English.
The presentation can be followed live via the link:
It will also be possible to take part of the audiocast afterwards at the same address or at Ascelia